Carson Wealth (CWM LLC)’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
PAI
6CM
Carson Wealth (CWM LLC)'s ANAB Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its AnaptysBio (ANAB) stake by 0.4% in Q1 2026, buying an estimated $215 and bringing the position to 1,015 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3728.
Carson Wealth (CWM LLC) first reported a position in ANAB in Q1 2023 and has held it in 11 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.
- Carson Wealth (CWM LLC) held 1,015 shares of AnaptysBio worth $56.3K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 4 AnaptysBio shares in Q1 2026, an estimated $215.
- AnaptysBio made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3728 holding.
- Carson Wealth (CWM LLC) first reported a position in AnaptysBio in Q1 2023 and has held it in 11 quarters since.
- 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.